MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
On February 11, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
Two more studies support (thrombectomy) mechanical clot retrieval for stroke.
Pilot trial of devices to extract clot from occluded arteries (PISTE)
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
At present it is not clear how best to organise NHS services so that patients can benefit from thrombectomy for stroke. The Institute of Heath Services, Newcastle University, has produced an online survey to understand the preferences of stroke survivors, their carers and the public on the future of stroke thrombectomy service organisation in the UK.
Exploring the effects of lowering blood pressure and a lower dose of clot busting drug on stroke outcome
Atrial fibrillation is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.